Dr. Inder Mohan Verma

Dr. Inder Mohan Verma is an Independent Director of Jubilant. Dr. Verma holds a masters’ degree in biochemistry from Lucknow University and a doctorate from Weizmann Institute of Science, Rehovoth, Israel. Dr. Inder Mohan Verma completed his post-doctoral training under the Nobel laureate, Dr. David Baltimore, at the Massachusetts Institute of Technology, USA. Dr. Verma joined the faculty of the Salk Institute, California in 1974, where he currently holds the Irwin and Joan Jacobs Chair in Exemplary Science and is also the director of the laboratory of genetics. Dr. Verma and his colleagues have pioneered the development of a gene therapy vector based on a stripped-down version of HIV that can deliver genes to non-dividing cells, which constitutes the majority of the cells in a human body. Dr. Verma has been on the editorial boards of a number of international scientific journals and has served as founding editor-in-chief of Molecular Therapy, a journal that focuses on gene therapy. He has been conferred with many honors and awards including one of 25 Lifetime American Cancer Society Professorships (1990) and Outstanding Investigator Award from the National Institutes of Health, USA (1988). Dr. Verma is also the recipient of the Cozzarelli Prize (2007), the Vilcek Prize (2008) and the Spector prize (2009). He was also conferred an honorary doctorate of science from the University of Hyderabad in 2009. Dr. Verma is the member of National Academy of Sciences (USA), Institute of Medicine, American Philosophical Society and is foreign associate of Indian Academy of Sciences. Dr. Verma has published over 300 scientific articles. He has served as a member of Jubilant’s Board since January 21, 2010.